Dr. Geschwind’s leadership as a principal investigator or co-investigator on more than 50 clinical trials has been instrumental in advancing new treatments. These trials explore a variety of novel therapies including cryoablation for breast cancer, endobronchial therapy for lung cancer, and ultrasound-guided noninvasive treatments for liver and kidney cancers. https://www.linkedin.com/in/jeff-geschwind-037200174